190P - 3-year follow-up of a phase III trial comparing the efficacy and safety of neoadjuvant and adjuvant trastuzumab and its biosimilar CT-P6 in HER2 positive early breast cancer (EBC)
| Autor: | Stebbing, J., Baranau, Y., Baryash, V., Manikhas, A., Moiseyenko, V., Dzagnidze, G., Zhavrid, E., Boliukh, D., Stroyakovskiy, D., Pikiel, J., Eniu, A., Komov, D., Lee, S.J., Kim, M.J., Kim, S., Park, S., Bae, J.H., Esteva, F.J. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v63-v64 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|